Literature DB >> 16946527

Study of the interaction of indirubin with bovine serum albumin.

Hedong Bian1, Mei Li, Qing Yu, Zhenfeng Chen, Jianniao Tian, Hong Liang.   

Abstract

This study examined the interaction of indirubin with bovine serum albumin (BSA) at three temperatures (286, 297, 308 K) at pH 7.40. In the presence of indirubin, the drug-BSA binding mode, binding constant and the protein structure changes in aqueous solution were determined by fluorescence quenching methods including Fourier transform infrared (FT-IR) spectroscopy and UV-Vis spectroscopy. The FT-IR change indicates that indirubin binds to BSA. The change in protein secondary structure accompanying ligand binding has been proved by fluorescence spectra data. The thermodynamic parameters, the enthalpy change (DeltaH), and the entropy change (DeltaS) calculated by the van't Hoff equation possess small negative (-2.744 kJ.mol(-1)) and positive values (112.756 J.mol(-1).K(-1)), respectively, which indicated that hydrophobic interactions play the main role in the binding of indirubin to BSA. Furthermore, the displacement experiment shows that indirubin can bind to the subdomain IIA and the distance between the tryptophan residues in BSA and indirubin bound to site I was estimated to be 2.24 nm according to Föster's equation on the basis of fluorescence energy transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946527     DOI: 10.1248/cpb.54.1239

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Study on the binding behavior of lysozyme with cephalosporin analogues by fluorescence spectroscopy.

Authors:  Zhuming Wang; Xijuan Tan; Donghua Chen; Qiaoli Yue; Zhenghua Song
Journal:  J Fluoresc       Date:  2009-04-03       Impact factor: 2.217

2.  Indirubin-pregnane X receptor-JNK axis accelerates skin wound healing.

Authors:  Yuka Tanaka; Hiroshi Uchi; Takamichi Ito; Masutaka Furue
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.